20 Sept 2026
A focused ophthalmology briefing. In your language.
A new review examines patient-reported outcomes after multifocal and extended depth-of-focus IOL implantation, including visual quality and spectacle independence.
Why it matters: A useful reading for the cataract consultation: different visual priorities are not captured by a single acuity measurement.
Read the briefA prospective multicentre, non-randomised device trial reports 24-month outcomes in 318 patients with glaucoma and cataract.
Why it matters: Relevant to the evidence map for combined cataract and glaucoma procedures.
Read the briefAt ESCRS 2026, ZEISS announced a toric IOL, a cataract configuration of EVA NEXUS and updates to digital surgical planning.
Why it matters: A concise map of the manufacturer’s latest workflow announcements, with a direct route to the original release.
Read the briefClinicalTrials.gov lists the phase II AVD-104 study as completed. The registry record was updated on 16 September; no results are posted in the retrieved record.
Why it matters: A concrete checkpoint for a geographic atrophy watchlist. Registry completion and publication of results are separate events.
Read the briefThe 26th EURETINA Congress takes place in Vienna on 1–4 October 2026. Innovation Spotlight precedes it on 30 September.
Why it matters: An upcoming checkpoint for retina research and technology. Use the official programme and registration links.
Read the briefFive essential updates, in your inbox. Free and easy to leave.